WAVE Life Sciences Ltd - ESG Rating & Company Profile powered by AI
This Disclosure score covers 17 UN SDGs including: 'Good Health & Wellbeing', 'Responsible Production & Consumption' and 'Life below Water'. This report of WAVE Life Sciences Ltd employs intelligence from across the internet and also from public disclosures by WAVE Life Sciences Ltd. Comprehensive ESG analysis of WAVE Life Sciences Ltd can be accessed by signing in.
WAVE Life Sciences Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.1; made up of an environmental score of 0.0, social score of 0.0 and governance score of 3.2.
1.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1779 | Taisho Pharmaceutical Holdings Co Ltd | 1.2 | Low |
| 1779 | VBI Vaccines Inc | 1.2 | Low |
| 1810 | WAVE Life Sciences Ltd | 1.1 | Low |
| 1810 | Captor Capital Corp | 1.1 | Low |
| 1810 | Century Therapeutics Inc | 1.1 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does WAVE Life Sciences Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes WAVE Life Sciences Ltd report the average age of the workforce?
Sign up for free to unlockDoes WAVE Life Sciences Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes WAVE Life Sciences Ltd offer flexible work?
Sign up for free to unlockDoes WAVE Life Sciences Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes WAVE Life Sciences Ltd conduct supply chain audits?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes WAVE Life Sciences Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose water use targets?
Sign up for free to unlockDoes WAVE Life Sciences Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid WAVE Life Sciences Ltd have a product recall in the last two years?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes WAVE Life Sciences Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas WAVE Life Sciences Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose parental leave metrics?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes WAVE Life Sciences Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes WAVE Life Sciences Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs WAVE Life Sciences Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose its waste policy?
Sign up for free to unlockDoes WAVE Life Sciences Ltd report according to TCFD requirements?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose energy use targets?
Sign up for free to unlockDoes WAVE Life Sciences Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes WAVE Life Sciences Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for WAVE Life Sciences Ltd
These potential risks are based on the size, segment and geographies of the company.
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders. In addition, it focuses on developing GalNAc-conjugated AIMers to treat hepatic indications comprising Alpha-1 antitrypsin deficiency (AATD); and two preclinical programs, such as Usher syndrome type 2A (USH2A) and retinitis pigmentosa due to a P23H mutation in the RHO gene (RhoP23H) for the treatment of retinal diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, University of Massachusetts, Western Washington University, Grenoble Institute of Neurosciences, IRBM S.p.A, University of Louisville, and University College London. The company was incorporated in 2012 and is based in Singapore.